15353-j-veluchamy

3 HLA independent killing of cervical tumors by UCB-NK cells | 91 tumor-infiltrating T cells. J Clin Oncol 33:1543-1550, 2015. 44. Goncalves MA, Le DM, Simoes RT, Rabreau M, Soares EG, Donadi EA, Carosella ED: Classical and non-classical HLA molecules and p16(INK4a) expression in precursors lesions and invasive cervical cancer. Eur J Obstet Gynecol Reprod Biol 141:70-74, 2008. 45. De Roock W, Claes B, Bernasconi D, De Schutter J, Biesmans B, Fountzilas G et al. : Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis. Lancet Oncol 11:753-762, 2010. 46. Bellone S, Frera G, Landolfi G, Romani C, Bandiera E, Tognon G et al. : Overexpression of epidermal growth factor type-1 receptor (EGF-R1) in cervical cancer: implications for Cetuximab-mediated therapy in recurrent/metastatic disease. Gynecol Oncol 106:513-520, 2007. 47. Meira DD, de Almeida VH, Mororo JS, Nobrega I, Bardella L, Silva RL et al. : Combination of cetuximab with chemoradiation, trastuzumab or MAPK inhibitors: mechanisms of sensitisation of cervical cancer cells. Br J Cancer 101:782-791, 2009. 48. Warren HS, Smyth MJ: NK cells and apoptosis. Immunol Cell Biol 77:64-75, 1999. 49. Boerman GH, van Ostaijen-ten Dam MM, Kraal KC, Santos SJ, Ball LM, Lankester AC et al. : Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells. Cancer Immunol Immunother 64:573-583, 2015. 50. Vieillard V, Baychelier F, Debre P: NKp44L: A new tool for fighting cancer. Oncoimmunology 3:e27988, 2014. 51. Cheng M, Chen Y, Xiao W, Sun R, Tian Z: NK cell-based immunotherapy for malignant diseases. Cell Mol Immunol 10:230-252, 2013. 52. Cany J, van der Waart AB, Tordoir M, Franssen GM, Hangalapura BN, de Vries J et al. : Natural killer cells generated from cord blood hematopoietic progenitor cells efficiently target bone marrow- residing human leukemia cells in NOD/SCID/IL2Rg(null) mice. PLoS One 8:e64384, 2013.